Clinical trial
Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer
NCT00004100 is registered in ClinicalTrials.gov with Istituto Nazionale per lo Studio e la Cura dei Tumori as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer
- Lead sponsor
- Istituto Nazionale per lo Studio e la Cura dei Tumori
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 30, 1998
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer